Speech Treatment for Minimally Verbal Children With ASD and CAS
Recruiting
Who can join
Ages 5 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * Meets criteria for Autism Spectrum Disorder * Able to correctly repeat at least 2 syllables * Meets criteria for Childhood Apraxia of Speech * Lives in an environment where child is exposed to English at least 50% of the time Exclusion Criteria: * Poorly controlled seizures * Factors such as blindness or deafness that contribute to minimally verbal status * Lives in an environment where English is not spoken at least 50% of the time * Child experiences behavioral challenges that preclude participation in the study
About the study
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.
What is being tested
- CAS Treatment for Minimally Verbal Children with Autism (behavioral)
Sponsor: MGH Institute of Health Professions · Participants: 20 · Started: May 1, 2024
Contact the study team
- Karen V Chenausky, Ph.D. · Phone: 617-726-2405
- Michael Moody · Phone: 617-643-4658
Official record on ClinicalTrials.gov — NCT05066178
Locations in the U.S.
| Massachusetts | MGH Institute of Health Professions, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.